| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
21,995 |
17,102 |
$2.25M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
7,758 |
5,912 |
$1.27M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
19,587 |
15,075 |
$1.26M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,333 |
1,777 |
$890K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
19,151 |
16,924 |
$661K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12,760 |
10,766 |
$531K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
5,730 |
4,372 |
$483K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
19,803 |
4,912 |
$397K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,332 |
1,712 |
$310K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
8,033 |
6,565 |
$310K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
5,792 |
3,397 |
$308K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
22,032 |
13,159 |
$201K |
| 71046 |
Radiologic examination, chest; 2 views |
5,683 |
4,257 |
$186K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
357 |
263 |
$185K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,604 |
2,946 |
$175K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
10,863 |
3,096 |
$174K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
8,799 |
6,106 |
$162K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,048 |
1,788 |
$156K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
6,955 |
4,679 |
$155K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
4,981 |
3,310 |
$139K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,782 |
2,825 |
$126K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
332 |
269 |
$122K |
| 80053 |
Comprehensive metabolic panel |
22,546 |
16,185 |
$120K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,019 |
1,419 |
$108K |
| G0378 |
Hospital observation service, per hour |
1,946 |
983 |
$103K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
23,188 |
15,831 |
$86K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
3,792 |
1,124 |
$78K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,087 |
1,530 |
$74K |
| 87631 |
|
721 |
671 |
$71K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,168 |
2,415 |
$64K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
954 |
920 |
$59K |
| 73630 |
|
963 |
753 |
$54K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,504 |
1,160 |
$54K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
683 |
572 |
$47K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,566 |
1,051 |
$45K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
168 |
123 |
$43K |
| 80061 |
Lipid panel |
4,808 |
4,022 |
$42K |
| 73610 |
|
814 |
613 |
$42K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
694 |
645 |
$41K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
10,674 |
7,737 |
$41K |
| 73030 |
|
783 |
576 |
$41K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
256 |
179 |
$39K |
| 97162 |
|
1,467 |
1,038 |
$39K |
| 71045 |
Radiologic examination, chest; single view |
1,674 |
1,187 |
$38K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
898 |
728 |
$37K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,844 |
2,984 |
$36K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
138 |
92 |
$36K |
| 96376 |
|
823 |
382 |
$34K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,771 |
1,471 |
$33K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,770 |
1,471 |
$33K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
507 |
396 |
$32K |
| 97161 |
|
1,213 |
997 |
$31K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
6,975 |
4,209 |
$30K |
| 72100 |
|
508 |
389 |
$27K |
| 73560 |
|
537 |
381 |
$27K |
| 84484 |
|
6,418 |
3,658 |
$26K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
5,682 |
5,185 |
$26K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,781 |
790 |
$24K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
56 |
39 |
$21K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
561 |
480 |
$21K |
| 80050 |
General health panel |
2,333 |
1,902 |
$20K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
322 |
293 |
$19K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
983 |
815 |
$19K |
| J2704 |
Injection, propofol, 10 mg |
3,181 |
2,169 |
$19K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
970 |
817 |
$18K |
| 73130 |
|
314 |
236 |
$17K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,080 |
2,521 |
$17K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
794 |
690 |
$17K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
4,722 |
3,547 |
$16K |
| 73110 |
|
253 |
187 |
$16K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
3,033 |
1,654 |
$16K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
248 |
239 |
$16K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,815 |
2,404 |
$16K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,900 |
1,566 |
$16K |
| 87428 |
|
269 |
259 |
$16K |
| 74018 |
|
370 |
280 |
$15K |
| 76830 |
Ultrasound, transvaginal |
148 |
112 |
$15K |
| 83690 |
|
4,292 |
3,172 |
$15K |
| 87081 |
|
3,316 |
2,794 |
$15K |
| 88342 |
|
916 |
691 |
$14K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,005 |
890 |
$14K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
365 |
293 |
$13K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
164 |
88 |
$13K |
| 85027 |
|
3,304 |
2,431 |
$13K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
683 |
587 |
$12K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
57 |
37 |
$12K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
524 |
438 |
$11K |
| 83880 |
|
850 |
591 |
$11K |
| 86803 |
|
1,049 |
907 |
$10K |
| 81001 |
|
5,789 |
4,194 |
$9K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
2,597 |
1,640 |
$9K |
| 93971 |
|
70 |
55 |
$9K |
| 84439 |
|
1,476 |
1,185 |
$9K |
| 81025 |
|
2,115 |
1,596 |
$8K |
| 82077 |
|
947 |
619 |
$8K |
| 82728 |
|
856 |
715 |
$8K |
| 87186 |
|
1,498 |
1,134 |
$7K |
| 83605 |
|
1,582 |
994 |
$7K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
198 |
180 |
$7K |
| 87040 |
|
1,519 |
633 |
$7K |
| 83735 |
|
2,091 |
1,276 |
$6K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,315 |
1,207 |
$6K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,654 |
2,746 |
$6K |
| 85610 |
|
3,225 |
1,726 |
$6K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,360 |
791 |
$6K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,338 |
728 |
$6K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,319 |
2,879 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
19,354 |
13,806 |
$5K |
| 84703 |
|
1,059 |
849 |
$5K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,248 |
1,048 |
$5K |
| 87077 |
|
769 |
572 |
$5K |
| 73564 |
|
41 |
31 |
$5K |
| J3490 |
Unclassified drugs |
1,345 |
900 |
$5K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
305 |
136 |
$5K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
628 |
534 |
$4K |
| 97035 |
|
406 |
120 |
$4K |
| 84702 |
|
435 |
314 |
$4K |
| 82962 |
|
3,403 |
1,069 |
$4K |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,523 |
532 |
$4K |
| 81003 |
|
4,291 |
3,367 |
$4K |
| 73502 |
|
126 |
89 |
$4K |
| 83550 |
|
637 |
538 |
$4K |
| 83540 |
|
823 |
678 |
$4K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,842 |
1,070 |
$3K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
90 |
73 |
$3K |
| 92558 |
|
234 |
225 |
$3K |
| 87088 |
|
1,407 |
1,090 |
$3K |
| 85652 |
|
1,869 |
1,375 |
$3K |
| 86141 |
|
357 |
268 |
$3K |
| 86850 |
|
520 |
364 |
$3K |
| 85379 |
|
564 |
411 |
$3K |
| 83655 |
|
321 |
241 |
$3K |
| 86710 |
|
292 |
253 |
$3K |
| 97116 |
|
331 |
99 |
$3K |
| 82607 |
|
380 |
303 |
$3K |
| 80143 |
|
340 |
186 |
$3K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
123 |
97 |
$3K |
| 99177 |
|
281 |
265 |
$3K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,057 |
1,340 |
$3K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
561 |
303 |
$3K |
| 94760 |
|
1,630 |
1,115 |
$3K |
| 80179 |
|
300 |
164 |
$2K |
| 87070 |
|
394 |
287 |
$2K |
| 80076 |
|
498 |
361 |
$2K |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
136 |
96 |
$2K |
| 86140 |
|
632 |
462 |
$2K |
| 82043 |
|
508 |
448 |
$2K |
| 84145 |
|
247 |
172 |
$2K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
17 |
12 |
$2K |
| 93017 |
|
20 |
12 |
$2K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
472 |
279 |
$2K |
| 90686 |
|
1,526 |
1,399 |
$2K |
| 59025 |
Fetal non-stress test |
42 |
25 |
$2K |
| 86618 |
|
142 |
127 |
$1K |
| 87340 |
|
203 |
164 |
$1K |
| 86900 |
|
668 |
472 |
$1K |
| 11721 |
|
222 |
149 |
$1K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
430 |
282 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
868 |
464 |
$1K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,085 |
746 |
$1K |
| 82784 |
|
119 |
81 |
$1K |
| 81002 |
|
973 |
755 |
$1K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
55 |
47 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
94 |
73 |
$1K |
| 83516 |
|
99 |
81 |
$1K |
| 86901 |
|
668 |
472 |
$1K |
| 97535 |
Self-care/home management training, each 15 minutes |
39 |
31 |
$1K |
| 36000 |
|
291 |
149 |
$974.31 |
| A9270 |
Non-covered item or service |
4,599 |
560 |
$941.40 |
| 73562 |
|
14 |
12 |
$859.17 |
| 86039 |
|
105 |
87 |
$836.98 |
| 87660 |
|
57 |
43 |
$773.27 |
| 90715 |
|
54 |
39 |
$760.55 |
| 87510 |
|
57 |
43 |
$736.62 |
| 87480 |
|
57 |
43 |
$736.60 |
| 80081 |
|
23 |
13 |
$657.55 |
| 84153 |
|
59 |
51 |
$617.69 |
| 76536 |
|
17 |
14 |
$610.22 |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
18 |
12 |
$590.41 |
| J2060 |
Injection, lorazepam, 2 mg |
729 |
430 |
$585.32 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
765 |
531 |
$565.00 |
| 11056 |
|
47 |
39 |
$504.37 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
390 |
191 |
$462.57 |
| 94761 |
|
350 |
91 |
$443.99 |
| 87205 |
|
110 |
82 |
$337.48 |
| G0008 |
Administration of influenza virus vaccine |
483 |
336 |
$320.10 |
| 88312 |
|
20 |
12 |
$295.01 |
| 20610 |
|
32 |
24 |
$283.39 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
47 |
27 |
$282.80 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
275 |
208 |
$268.46 |
| 86364 |
|
38 |
25 |
$239.35 |
| 81015 |
|
112 |
83 |
$225.49 |
| 97010 |
|
31 |
13 |
$215.13 |
| 86706 |
|
26 |
24 |
$208.32 |
| 87147 |
|
40 |
39 |
$199.19 |
| 82550 |
|
41 |
25 |
$177.31 |
| 84550 |
|
53 |
38 |
$174.79 |
| 84481 |
|
14 |
12 |
$174.45 |
| 90656 |
|
246 |
243 |
$145.98 |
| 86431 |
|
39 |
37 |
$145.34 |
| 82140 |
|
19 |
13 |
$128.96 |
| 82950 |
|
40 |
29 |
$118.24 |
| 90662 |
|
111 |
74 |
$92.38 |
| 86592 |
|
30 |
26 |
$83.27 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
148 |
37 |
$79.82 |
| 92551 |
|
18 |
16 |
$76.83 |
| 82565 |
|
23 |
14 |
$75.16 |
| 99306 |
Prolong nursin fac eval 15m |
22 |
13 |
$73.46 |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
28 |
12 |
$48.95 |
| 82570 |
|
12 |
12 |
$42.86 |
| 87420 |
|
33 |
33 |
$42.50 |
| 85018 |
|
36 |
26 |
$39.62 |
| 87210 |
|
19 |
14 |
$34.16 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
94 |
40 |
$24.69 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
134 |
88 |
$0.04 |
| 90677 |
|
28 |
24 |
$0.01 |
| 1123F |
|
662 |
353 |
$0.00 |
| 3074F |
|
77 |
58 |
$0.00 |
| 3078F |
|
86 |
59 |
$0.00 |
| 90670 |
|
25 |
25 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
215 |
106 |
$0.00 |
| G8484 |
Influenza immunization was not administered, reason not given |
203 |
114 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
138 |
72 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
19 |
12 |
$0.00 |